Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

nintedanib

UK Life Sciences Strategy - one year on

UK to introduce DNA mapping for cancer and rare diseases

Will sequence the genomes of up to 100,000 patients within five years

- PMLiVE

Boehringer takes leukaemia drug volasertib into phase III

Shows positive results in a difficult-to-treat patient population

Stephen Whitehead appointed HCA president

ABPI head joins comms association as exec committee is reorganised

- PMLiVE

1992 – 2012: The ethics we work within

When commercialisation of the internet began in the 1990s we could never have anticipated how significant a part audience ‘pull’ of information would become. So is it pharma and its...

- PMLiVE

Merz, Lilly and Daiichi-Sankyo breach ABPI code

Pharma companies 'named and shamed' for inappropriate marketing in the UK

ABPI London offices

Biosimilars should be routinuely assessed by NICE, says ABPI

Calls for biosimilars to go through full HTA process

- PMLiVE

Boehringer launches COPD awareness drive in Japan

Social media campaign will target male smokers’ wives and daughters

- PMLiVE

NHS data is key to sustaining drug research in UK

ABPI, BIA and NOCRI event told shared knowledge is central to effective partnerships

- PMLiVE

Medicines key to new NHS Mandate, says ABPI

Government sets objectives for NHS Commissioning Board to improve patient care in England

- PMLiVE

Boehringer launches online education portal for hepatitis C

Comes as company moves its interferon-free hep C regimen into phase III

- PMLiVE

NHS needs to invest for longer term savings, says ABPI

Chief executive Stephen Whitehead accuses health service of not seizing innovation

- PMLiVE

ABPI appoints Pfizer’s Colette Goldrick as first Northern Ireland director

Will develop relationships with key opinion leaders in region

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links